Use Dividend Data: https://www.dividenddata.com/

AI-generated source summary

The analysis evaluates Salesforce (CRM) following its Q3 2026 earnings, which reported an adjusted EPS of $3.25, surpassing analyst estimates. Revenue growth for Q3 was 9% year-over-year, with subscription and support revenue up 10%. Salesforce maintains its FY26 full-year revenue guidance of $41.45 billion to $41.55 billion, indicating 9-10% year-over-year growth, and has raised its operating cash flow growth guidance to 13-14%. Despite these positive financial indicators, the stock has experienced significant underperformance, declining 28% over the past year and 35% from its peak. The forward P/E ratio stands at 20, a historical low compared to previous years when it traded much higher. A discounted cash flow (DCF) model, incorporating revenue growth projections up to 9% annually, EBIT margins of 34-36%, and low capital expenditure, suggests an intrinsic value ranging from $198.54 (based on a 16.6x free cash flow multiple) to $365.04 (based on a 30x free cash flow multiple). Wall Street analysts share a consensus target price of $366.30. The analysis identifies slowing revenue growth and AI-related risks, such as potential automation impacting seat-based revenue and increased competition from AI-driven solutions, as factors contributing to the stock's decline. However, it also highlights the robust growth of Salesforce's AI product, Agentforce (114% Y-o-Y increase in ARR to $1.4 billion), and high customer switching costs due to extensive ecosystem integration, positioning the stock as a long-term buying opportunity despite current market perception.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   04 Dec 2025, 05:08 UTC

   The analyst published the original source item.

2. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

3. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.

4. Outcome tracking started

   02 Jul 2026, 01:22 UTC

   Tahlil Plus began monitoring the extracted predictions.

5. First prediction resolved

   02 Jul 2026, 01:22 UTC

   The first evaluable outcome in this case reached a terminal result.

6. Case evaluation completed

   02 Jul 2026, 01:22 UTC

   All evaluable predictions in this case reached terminal outcomes.